Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 153

1.

Intraarterial contrast-enhanced MR aortography with and without parallel acquisition technique in patients with peripheral arterial occlusive disease.

Potthast S, Bongartz GM, Huegli R, Schulte AC, Schwarz JG, Aschwanden M, Bilecen D.

AJR Am J Roentgenol. 2007 Mar;188(3):823-9.

PMID:
17312074
2.

Lower extremity: low-dose contrast agent intraarterial MR angiography in patients--initial results.

Bilecen D, Schulte AC, Heidecker HG, Aschwanden M, Huegli R, Jaeger KA, Ostheim-Dzerowycz W, Bongartz G.

Radiology. 2005 Jan;234(1):250-5.

PMID:
15564395
3.

Effect of bolus length of intraarterial injections on contrast-enhanced MR-angiography in patients.

Hashagen C, Schulte AC, Bongartz G, Aschwanden M, Jaeger KA, Huegli R, Jacob AL, Bilecen D.

J Magn Reson Imaging. 2007 Apr;25(4):841-7.

PMID:
17345642
4.

Time-resolved 3D MR angiography of the foot at 3 T in patients with peripheral arterial disease.

Ruhl KM, Katoh M, Langer S, Mommertz G, Guenther RW, Niendorf T, Spuentrup E.

AJR Am J Roentgenol. 2008 Jun;190(6):W360-4. doi: 10.2214/AJR.07.2545.

PMID:
18492878
6.

Post-processing central k-space subtraction for high-resolution arterial peripheral MR angiography.

Gedat E, Mohajer M, Kirsch R, Frericks B.

Magn Reson Imaging. 2011 Jul;29(6):835-43. doi: 10.1016/j.mri.2011.03.002.

PMID:
21546189
7.

Intraarterial gadolinium-enhanced magnetic resonance angiography of the renal arteries in humans: feasibility, contrast agent reduction, and accuracy for detection of stenoses.

Zorger N, Jung EM, Hamer OW, Paetzel C, Schreyer A, Seitz J, Stehr A, Steinbauer M, Feuerbach S, Herold T.

Clin Hemorheol Microcirc. 2008;38(2):97-104.

PMID:
18198411
8.

Three-dimensional cerebral contrast-enhanced magnetic resonance venography at 3.0 Tesla: initial results using highly accelerated parallel acquisition.

Nael K, Fenchel M, Salamon N, Duckwiler GR, Laub G, Finn JP, Villablanca JP.

Invest Radiol. 2006 Oct;41(10):763-8.

PMID:
16971800
9.

Validation of injection parameters for catheter-directed intraarterial gadolinium-enhanced MR angiography.

Omary RA, Henseler KP, Unal O, Smith RJ, Ryu RK, Resnick SA, Saker MB, Chrisman HB, Frayne R, Finn JP, Li D, Grist TM.

Acad Radiol. 2002 Feb;9(2):172-85.

PMID:
11918370
10.

Contrast-enhanced magnetic resonance angiography of the lower extremities: standard-dose vs. high-dose gadodiamide injection.

Krause U, Kroencke T, Spielhaupter E, Taupitz M, Kenn W, Hamm B, Hahn D.

J Magn Reson Imaging. 2005 Apr;21(4):449-54.

PMID:
15778953
11.

Comparison of intraarterial and IV gadolinium-enhanced MR angiography with digital subtraction angiography for the detection of renal artery stenosis in pigs.

Omary RA, Henseler KP, Unal O, Maciolek LJ, Finn JP, Li D, Nemcek AA Jr, Vogelzang RL, Grist TM.

AJR Am J Roentgenol. 2002 Jan;178(1):119-23.

PMID:
11756103
12.

Diagnostic pitfalls in postinterventional intraarterial magnetic resonance angiography after recanalization of femoropopliteal arterial occlusions.

Huegli RW, Aschwanden M, Kos S, Rasmus M, Jaeger K, Jacob AL, Bilecen D.

Acta Radiol. 2008 Dec;49(10):1129-36. doi: 10.1080/02841850802508942.

PMID:
19031180
13.

Intraarterial contrast material-enhanced magnetic resonance angiography of the aortoiliac system.

Paetzel C, Zorger N, Seitz J, Völk M, Nitz WR, Herold T, Feuerbach S, Lenhart M.

J Vasc Interv Radiol. 2004 Sep;15(9):981-4.

PMID:
15361566
14.

Optimisation of a high-resolution whole-body MR angiography protocol with parallel imaging and biphasic administration of a single bolus of Gd-BOPTA: preliminary experience in the systemic evaluation of atherosclerotic burden in patients referred for endovascular procedures.

Napoli A, Anzidei M, Marincola BC, Zaccagna F, Geiger D, Di Paolo PL, Zini C, Catalano C, Passariello R.

Radiol Med. 2009 Jun;114(4):538-52. doi: 10.1007/s11547-009-0384-8. English, Italian.

PMID:
19430733
15.

Low-dose intra-arterial contrast-enhanced MR aortography in patients based on a theoretically derived injection protocol.

Potthast S, Schulte AC, Bongartz GM, Hügli R, Aschwanden M, Bilecen D.

Eur Radiol. 2005 Nov;15(11):2347-53.

PMID:
15968517
16.

Diagnostic performance of gadobenate dimeglumine enhanced MR angiography of the iliofemoral and calf arteries: a large-scale multicenter trial.

Thurnher S, Miller S, Schneider G, Ballarati C, Bongartz G, Herborn CU, Schoenberg S, Cova MA, Morana G, Niazi K, Iezzi R, Taupitz M, Bluemke DA, Kreitner KF, Kirchin MA, Pirovano G.

AJR Am J Roentgenol. 2007 Nov;189(5):1223-37.

PMID:
17954665
17.

Comparison of contrast-enhanced MR angiography to intraarterial digital subtraction angiography for evaluation of peripheral arterial occlusive disease: results of a phase III multicenter trial.

Bui BT, Miller S, Mildenberger P, Sam A 2nd, Sheng R; Omniscan MRA Investigator Panel..

J Magn Reson Imaging. 2010 Jun;31(6):1402-10. doi: 10.1002/jmri.22086.

PMID:
20512893
18.

Low injection rate for 3D moving-table bolus-chase MR angiography: initial experience with 3-T imaging to allay venous contamination in the calf.

Lin K, Zhang ZQ, Sun JY, Fan ZM, Lu B.

AJR Am J Roentgenol. 2008 Dec;191(6):1734-9. doi: 10.2214/AJR.07.3665.

PMID:
19020244
19.

Reproducibility of the aortic input function (AIF) derived from dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) of the kidneys in a volunteer study.

Mendichovszky IA, Cutajar M, Gordon I.

Eur J Radiol. 2009 Sep;71(3):576-81. doi: 10.1016/j.ejrad.2008.09.025.

PMID:
19004588
20.

Development of intraarterial contrast-enhanced 2D MRDSA with a 0.3 tesla open MRI system.

Masumoto T, Hayashi N, Mori H, Aoki S, Abe O, Ohtomo K, Abe T, Takahashi T.

Magn Reson Med Sci. 2003 Jul 1;2(2):97-103.

Supplemental Content

Support Center